Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Brexanolone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 236,107Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lipocine Announces Regulatory Pathway on Oral LPCN 1154 for PPD
    Lipocine Announces Regulatory Pathway on Oral LPCN 1154 for PPD

    15 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lipocine-announces-favorable-regulatory-pathway-on-oral-lpcn-1154-for-post-partum-depression-ppd-301624932.html

    PRNEWSWIRE
    15 Sep 2022
    Share Share
    Blasted by PhIII failure, a struggling Sage axes 340 staffers and bunkers down
    Blasted by PhIII failure, a struggling Sage axes 340 staffers and bunkers down

    08 Apr 2020

    // John Carroll ENDPTS

    https://endpts.com/blasted-by-phiii-failure-a-struggling-sage-axes-340-staffers-and-bunkers-down-to-survive-the-storm/

    John Carroll ENDPTS
    08 Apr 2020
    Share Share
    Sage Therapeutics to halve its total workforce in radical cost-cutting move
    Sage Therapeutics to halve its total workforce in radical cost-cutting move

    08 Apr 2020

    // PHARMAFILE

    http://www.pharmafile.com/news/545912/sage-therapeutics-halve-its-total-workforce-radical-cost-cutting-move

    PHARMAFILE
    08 Apr 2020
    Share Share
    Sage's new drug starts slow, as Wall Street waits for depression data
    Sage's new drug starts slow, as Wall Street waits for depression data

    14 Nov 2019

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/sage-zulresso-slow-start-focus-depression-data-mountain/567234/

    BIOPHARMADIVE
    14 Nov 2019
    Share Share
    Sage strategy for postpartum depression drug Zulresso keys on patient support
    Sage strategy for postpartum depression drug Zulresso keys on patient support

    01 Jul 2019

    // Beth Snyder FIERCE PHARMA

    https://www.fiercepharma.com/marketing/soft-launch-sage-strategy-for-postpartum-depression-drug-zulresso-keys-awareness-and

    Beth Snyder FIERCE PHARMA
    01 Jul 2019
    Share Share
    FDA approves first drug specifically for postpartum depression
    FDA approves first drug specifically for postpartum depression

    25 Mar 2019

    // Maggie Lynch IN-PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2019/03/25/FDA-approves-first-drug-specifically-for-postpartum-depression

    Maggie Lynch IN-PHARMATECHNOLOGIST
    25 Mar 2019
    Share Share